Skip to content
Screener

Price / book at other companies

Sarepta Therapeutics, Inc. logo
Sarepta Therapeutics, Inc.SRPT
1.2×-0.1×
Ultragenyx Pharmaceutical logo
Ultragenyx PharmaceuticalRARE
316.5×+303×
Viridian Therapeutics, Inc. logo
Viridian Therapeutics, Inc.VRDN
3.1×+0.7×
Regenxbio logo
RegenxbioRGNX
8.6×+6.6×
Zevra Therapeutics, Inc. logo
Zevra Therapeutics, Inc.ZVRA
3.9×-0.4×
Kyverna Therapeutics, Inc. logo
Kyverna Therapeutics, Inc.KYTX
2.7×+2.3×

Other financials

Income statement

See full
Revenue$116.4M+31.9%
Operating income$53.7M+48.1%
Net income$55.9M+56.5%
EPS (diluted)$1.83+52.5%

Balance sheet

See full
Cash & equivalents$501.3M+62.4%
Total debt$9.1M-5.7%
Total equity$1.3B+29.7%
Total assets$1.4B+30.0%

Cash flow

See full
Operating cash flow$80.4M+160%
CapEx$7.1M+15.2%
Free cash flow$73.2M+196%

Valuation

See full
Market cap$9.64B+145%
Enterprise value$9.15B+155%
P/E42.9×+16.0×
P/S23.1×+12.2×

Profitability

See full
Operating margin42.8%+10.2pp
Net margin53.9%+16.7pp
FCF margin56.9%+16.5pp

Returns & leverage

See full
Return on equity19.9%+6.0pp
Debt / equity0.0×
Current ratio9.5×-0.2×

Where this comes from

Calculated from Krystal Biotech, Inc.’s reported figures.

Based on the most recent quarter.

The source filing: Krystal Biotech, Inc.’s 10-Q, filed May 4, 2026. Open the filing →

Filed
May 4, 2026, 7:06 AM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001711279-26-000043

FAQ

What is Krystal Biotech, Inc.'s price / book?
Krystal Biotech, Inc. (KRYS) reported price / book of 5.9× in Q1 2026.
How has Krystal Biotech, Inc.'s price / book changed year-over-year?
Krystal Biotech, Inc.'s price / book increased by 12.1% year-over-year, from 5.3× to 5.9×.
What is the long-term trend for Krystal Biotech, Inc.'s price / book?
Over 5 years (2020 to 2025), Krystal Biotech, Inc.'s price / book has grown at a 2.8% compound annual growth rate (CAGR), from 5.1× to 5.9×.
What does price / book mean?
Market capitalization at the quarter end divided by shareholders' equity. The premium (or discount) the market assigns to the company's book equity.

Ask your AI about Krystal Biotech, Inc.'s price / book.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude